Roberts Zachary 4
4 · Allogene Therapeutics, Inc. · Filed Jan 24, 2023
Insider Transaction Report
Form 4
Roberts Zachary
EVP of R&D
Transactions
- Award
Stock Option (Right to Buy)
2023-01-20+873,015→ 873,015 totalExercise: $6.55Exp: 2033-01-20→ Common Stock (873,015 underlying) - Award
Common Stock
2023-01-20+251,908→ 251,908 total
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on January 03, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.